Baxter International Inc. (BAX) Stock Quote

Detailed Quote for Baxter International Inc. (BAX)

After Hours: $ 56.84

0.00 (0.00%)

Volume: 49.25 k

4:58 PM EST Feb 10, 2012

close 52 Week Information

52 Week High

July 21, 2011

Close: 62.50

52 Week Low

December 19, 2011

Close: 47.5518

Today

Last Price
56.84

Change $
0.04

Change %
0.07%

Tick
N/A

Bid
56.41

Bid Size
200

Ask
57.17

Ask Size
200

Open
56.52

High
56.84

Low
56.2101

Prev Close
56.80

Last Trade
2/10/12

Volume
2.61 m

52 Wk Hi
62.50

52 Wk Low
47.5518

Market Cap
32.05 b

Ex-Div Date
12/7/11

Div Rate
1.34

Yield
2.3575

Shares
563,866,130

EPS (TTM)
3.88

PE Ratio
14.60

close Exchange Information Listed On New York Stock Exchange (NYE) Exchange
NYE

News and Media for Baxter International Inc. (BAX)

Sector News | Topic News

News for BAX

Mon, Jan 30, 2012

9:00 AM

Baxter Announces FDA Approval of Expanded Indication for TISSEEL [Fibrin Sealant] for General Hemostasis in Surgery - Business Wire

Thu, Jan 26, 2012

7:00 AM

Baxter Reports Sales and EPS for Fourth Quarter and Full-Year 2011 in Line with Guidance - Business Wire

Tue, Jan 24, 2012

9:00 AM

Mt. Ascutney Hospital and Health Center in Vermont Receives Prestigious $100,000 Foster G. McGaw Prize for Excellence in Community Service - Business Wire

Mon, Jan 23, 2012

5:42 PM

Baxter to Initiate Second Phase III Trial Studying GAMMAGARD LIQUID (IGIV) for the Treatment of Alzheimer's Disease - Business Wire

Mon, Jan 09, 2012

4:15 PM

Baxter Appoints Jean-Luc Butel as President, International - Business Wire

9:00 AM

Baxter Submits Application for FDA Approval of GAMMAGARD LIQUID to Treat Multifocal Motor Neuropathy, a Degenerative Neurological Disorder - Business Wire

Thu, Jan 05, 2012

8:30 AM

Baxter Initiates Phase I Clinical Trial of Longer-Acting Recombinant FVIII Treatment for Hemophilia A - Business Wire

Wed, Jan 04, 2012

5:12 PM

Baxter Recommends Shareholders Reject "Mini-Tender" Offer by TRC Capital - Business Wire

Thu, Dec 22, 2011

4:15 PM

Baxter and Momenta Announce Collaboration to Develop and Commercialize Follow-On Biologics - Business Wire

Wed, Dec 21, 2011

9:15 AM

Baxter to Present at the 30th Annual J.P. Morgan Health Care Conference - Business Wire

Fri, Dec 16, 2011

9:15 AM

FDA Approves Baxter's ADVATE as the Only FVIII for Routine Prophylaxis in Both Adults and Children With Hemophilia A - Business Wire

Thu, Dec 15, 2011

11:25 AM

The Law Firm of Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty by the Board of Synovis Life Technologies Inc. in Connection With the Sale of the Company to Baxter International Inc. - Marketwire

9:00 AM

Baxter Responds to Patient Needs in Aftermath of Thailand Floods - Business Wire

Tue, Dec 13, 2011

11:44 AM

The Law Firm of Levi & Korsinsky, LLP Announces Investigation Into Possible Breaches of Fiduciary Duty by the Board of Synovis Life Technologies Inc. in Connection With the Sale of the Company to Baxter International Inc. - PR Newswire

8:00 AM

Baxter Signs Definitive Agreement to Acquire Synovis - Business Wire

Wed, Nov 30, 2011

8:10 AM

Equity Research on Baxter International Inc. and Thermo Fisher Scientific Inc. - Acquisitions and R&D Driving Medical Instruments and Supplies - Marketwire

Thu, Nov 17, 2011

4:15 PM

Baxter to Present at the 23rd Annual Piper Jaffray Health Care Conference - Business Wire

10:14 AM

S&P Capital IQ Publishes Quality Trends, An In-Depth Analysis of "Quality" in the Equity Markets - PR Newswire

Tue, Nov 15, 2011

9:15 AM

Baxter Raises Quarterly Dividend - Business Wire

Mon, Nov 07, 2011

9:01 AM

Baxter Corporation and Medbuy First Trading Partners in Canada to Synchronize Medical-Surgical Product Data - Canada Newswire

More News for BAX >>

Tags for Baxter International Inc.

Research stocks or mutual funds related to Baxter International Inc. by keywords or tags. Find companies that have a similar focus to BAX. The keywords below have been associated to BAX by either user submission or electronic means.

education resources biotechnology company baxter infusion pumps biotech research pharmaceuticals research pharmaceuticals international research experiential education pharmaceutical industry strategy baxter as50 pharmaceutical market corporate governance training kidney pharmaceuticals companies generic pharmaceutical niche pharmaceutical environmental sustainability nurses for continuing education kidney dialysis continuing professional education pharma strategy baxter work baxter of california biotechnology market continuing education fujisawa pharmaceutical pharmaceutical research and development education distance learning pharmaceutical manufacturing company volumetric pumps vocational education education family business governance social responsibility report pharma marketing baxter robertson andrew baxter education courses online corporate governance education guide governance consultant pharma manufacturing governance consulting les baxter continuing course education medical pharma license gifted education novartis pharmaceuticals report on corporate governance baxter stock syringe infusion pump